EARNEST Partners’s Celgene Corp CELG Stock Holding History

EARNEST Partners’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-358	Closed	-$36K	–	1214
2019 Q3	$36K	Hold	358	–	–	﹤0.01%	347
2019 Q2	$33K	Hold	358	–	–	﹤0.01%	361
2019 Q1	$34K	Hold	358	–	–	﹤0.01%	353
2018 Q4	$23K	Hold	358	–	–	﹤0.01%	405
2018 Q3	$32K	Hold	358	–	–	﹤0.01%	359
2018 Q2	$28K	Hold	358	–	–	﹤0.01%	376
2018 Q1	$32K	Hold	358	–	–	﹤0.01%	358
2017 Q4	$37K	Buy	+358	New	+$40.4K	﹤0.01%	337
2017 Q1	–	Sell	-358	Closed	-$41K	–	1172
2016 Q4	$41K	Buy	+358	New	+$39.9K	﹤0.01%	304

Other funds holding CELG

HCM

Howard Capital Management Roswell, Georgia $8.4B AUM 51.89% 1-Year Est. Return

PCMC

Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return

WCG

Weaver Consulting Group Huntington Beach, California $488M AUM 17.59% 1-Year Est. Return

EARNEST Partners's CELG Position: Q4 2019 in Review

EARNEST Partners sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 358 shares — an estimated $36K sold.

EARNEST Partners first reported a position in CELG in Q4 2016 and held it in 9 quarters. The position peaked at $41K in Q4 2016. 3 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

EARNEST Partners reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
EARNEST Partners sold 358 Celgene Corp shares in Q4 2019, an estimated $36K.
EARNEST Partners first reported a position in Celgene Corp in Q4 2016 and held it in 9 quarters.
EARNEST Partners's Celgene Corp position peaked at $41K in Q4 2016.
3 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on EARNEST Partners's 13F filing for Q4 2019, filed 7 Feb 2020.